CCR4 抗体
(Chemokine (C-C Motif) Receptor 4 (CCR4))
The protein encoded by this gene belongs to the G-protein-coupled receptor family . It is a receptor for the CC chemokine - MIP-1, RANTES, TARC and MCP-1. Chemokines are a group of small polypeptide, structurally related molecules that regulate cell trafficking of various types of leukocytes. The chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CCR4 抗体 (AA 201-300) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CCR4 抗体 (Extracellular Domain) | 人, 猴 | 山羊 Polyclonal |
|
|
|
| CCR4 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (Extracellular Domain) | 人, 猴 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 309-360) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 17-39) | 人 | 山羊 Polyclonal |
|
|
|
| CCR4 抗体 (AA 180-229) | 人, 小鼠, 大鼠, Cow, 犬 | 兔 Polyclonal |
|
|
|
| Recombinant CCR4 抗体 | 人 | Human, 兔 Chimeric |
|
|
|
| CCR4 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (Middle Region) | 人, 小鼠, 大鼠, Cow, 犬 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 337-351) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CCR4 抗体 (AA 201-300) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 猴
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Extracellular Domain
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Extracellular Domain
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 309-360
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB22223
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 262-290, C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 17-39
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- DMC297
- 标记
- unconjugated
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 201-300
Latest Publications for our CCR4 抗体
: "A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer." in: The Journal of clinical investigation, Vol. 127, Issue 3, pp. 801-813, (2017) (PubMed).
: "Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome." in: PLoS pathogens, Vol. 12, Issue 1, pp. e1005375, (2016) (PubMed).
: "Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 197, Issue 2, pp. 655-64, (2016) (PubMed).
: "Integration of nondegradable polystyrene and degradable gelatin in a core-sheath nanofibrous patch for pelvic reconstruction." in: International journal of nanomedicine, Vol. 10, pp. 3193-201, (2015) (PubMed).
: "GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation." in: PLoS ONE, Vol. 9, Issue 1, pp. e85058, (2014) (PubMed).
: "Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer." in: Journal of translational medicine, Vol. 12, pp. 61, (2014) (PubMed).
: "CCR5 plays an important role in resolving an inflammatory response to single-walled carbon nanotubes." in: Journal of applied toxicology : JAT, Vol. 33, Issue 8, pp. 845-53, (2013) (PubMed).
: "Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus." in: Journal of dermatological science, Vol. 71, Issue 1, pp. 22-8, (2013) (PubMed).
: "Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 8, pp. 2224-31, (2013) (PubMed).
: "Identification of human NK17/NK1 cells." in: PLoS ONE, Vol. 6, Issue 10, pp. e26780, (2011) (PubMed).
: "Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome." in: PLoS pathogens, Vol. 12, Issue 1, pp. e1005375, (2016) (PubMed).
: "Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 197, Issue 2, pp. 655-64, (2016) (PubMed).
: "Integration of nondegradable polystyrene and degradable gelatin in a core-sheath nanofibrous patch for pelvic reconstruction." in: International journal of nanomedicine, Vol. 10, pp. 3193-201, (2015) (PubMed).
: "GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation." in: PLoS ONE, Vol. 9, Issue 1, pp. e85058, (2014) (PubMed).
: "Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer." in: Journal of translational medicine, Vol. 12, pp. 61, (2014) (PubMed).
: "CCR5 plays an important role in resolving an inflammatory response to single-walled carbon nanotubes." in: Journal of applied toxicology : JAT, Vol. 33, Issue 8, pp. 845-53, (2013) (PubMed).
: "Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus." in: Journal of dermatological science, Vol. 71, Issue 1, pp. 22-8, (2013) (PubMed).
: "Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 8, pp. 2224-31, (2013) (PubMed).
: "Identification of human NK17/NK1 cells." in: PLoS ONE, Vol. 6, Issue 10, pp. e26780, (2011) (PubMed).
Aliases for CCR4 抗体
C-C motif chemokine receptor 4 (CCR4) 抗体C-C motif chemokine receptor 4 (Ccr4) 抗体
chemokine (C-C motif) receptor 4 (Ccr4) 抗体
C-C CKR-4 抗体
CC-CKR-4 抗体
Ccr4 抗体
CD194 抗体
CHEMR1 抗体
ChemR13 抗体
CKR4 抗体
CMKBR4 抗体
Cmkbr4 抗体
HGCN:14099 抗体
K5-5 抗体
LESTR 抗体
Sdf1r 抗体
您还需要查找其他产品吗？
You are here:
